Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Cantor Fitzgerald
Deloitte
Mallinckrodt
Cerilliant
Fish and Richardson
Healthtrust
AstraZeneca
Harvard Business School
Teva

Generated: January 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,282,251

« Back to Dashboard

Summary for Patent: 4,282,251
Title: Trans-n-cinnamyl-n-methyl-(1-naphthylmethyl)amine
Abstract:Cinnamylalkyl-1-naphthylmethylamines, useful as antimycotic agents, and processes for their production.
Inventor(s): Berney; Daniel (Lausanne, CH)
Assignee: Sandoz Ltd. (Basel, CH)
Application Number:06/100,024
Patent Claim Types:
see list of patent claims
Compound; Composition; Use;

Drugs Protected by US Patent 4,282,251

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,282,251

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Switzerland5335/76Apr 28, 1976
Switzerland16182/76Dec 22, 1976
Switzerland920/77Jan 26, 1977
Switzerland921/77Jan 26, 1977

International Patents Family Members for US Patent 4,282,251

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
France 2349566 ➤ Subscribe
Hong Kong 71884 ➤ Subscribe
United Kingdom 1579879 ➤ Subscribe
United Kingdom 1579878 ➤ Subscribe
Austria 370406 ➤ Subscribe
Austria A8079 ➤ Subscribe
Austria A293677 ➤ Subscribe
Austria 362348 ➤ Subscribe
Australia 513249 ➤ Subscribe
Australia 2459177 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Covington
Queensland Health
McKinsey
Deloitte
Chinese Patent Office
Boehringer Ingelheim
Moodys
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot